LIVINGSTON RANDALL S 4

4 · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · Filed Feb 17, 2021

Form 4

Period: 2021-02-12

Director

Transactions

Exercise/Conversion
Common Stock
2021-02-12$10.58/sh+17,500$185,150→ 17,500 total
Exercise/Conversion
Stock Option (right to buy)
2021-02-12−17,500→ 0 total
Exercise: $10.58Exp: 2021-06-23→ Common Stock (17,500 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-02-12−25,000→ 0 total
Exercise: $1.83Exp: 2022-06-13→ Common Stock (25,000 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-02-12−25,000→ 0 total
Exercise: $2.54Exp: 2023-05-21→ Common Stock (25,000 underlying)
Exercise/Conversion
Common Stock
2021-02-12$1.83/sh+25,000$45,750→ 42,500 total
Exercise/Conversion
Common Stock
2021-02-12$2.54/sh+25,000$63,500→ 67,500 total
Sale
Common Stock
2021-02-12$48.07/sh−67,500$3,244,455→ 0 total

Footnotes (2)

[F1]This sale price represents the weighted average sale price of the shares sold ranging from $48.00 to $48.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F2]The shares subject to the option are fully vested and exercisable.

Documents

1 file